Tuesday, March 17, 2026

BlackRock Acquires 5.01% Stake in HLB: What This Means for Investors

BlackRock acquires a 5.01% stake in HLB, becoming the second-largest shareholder, signaling confidence in HLB's liver cancer drug.

Trump’s 25% Tariff Threat Leaves Seoul Empty-Handed: Washington Meetings Stall as Korea’s National Assembly Gridlock Bites

South Korea struggles in trade talks with the U.S. due to domestic legislative gridlock and increasing tariff threats from Trump.

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

Tag: Elementary School

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.